1
Contingency Management Treatment Duration
Condition(s): Alcohol Abuse Last Updated: January 15, 2013Recruiting
9976 Clinical Trials for: Treatment Duration, Page 1 of 499
Hide Studies Not Seeking New Volunteers
2
Effects of Extended Haemodialysis Treatment Duration in Patients With End-stage Renal Disease
Condition(s): End Stage Renal Disease Last Updated: November 2, 2012Recruiting
3
Treatment's Duration of Acute Uncomplicated Pyelonephritis
Condition(s): Urinary Tract Infection; Fever Last Updated: December 12, 2011Completed
4
Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma
Condition(s): Renal Cell Carcinoma Last Updated: May 8, 2013Recruiting
5
Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE)
Condition(s): Chronic Hepatitis Last Updated: April 14, 2012Recruiting
6
Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia
Condition(s): Cervical Dystonia Last Updated: February 22, 2012Completed
7
Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART)
Condition(s): Colorectal Cancer Last Updated: May 7, 2013Recruiting
8
Treatment Duration for Abdominal Tuberculosis
Condition(s): Treatment Duration for Abdominal Tuberculosis Last Updated: December 12, 2011Recruiting
9
Evaluation of Optimal Initial Treatment Duration of Bevacizumab in Combination With Standard Chemotherapy in Patients With Ovarian Cancer
Condition(s): Genital Diseases, Female; Ovarian Diseases; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms Last Updated: May 29, 2012Recruiting
10
Study of Response in Chronic Hepatitis C (CHC) Patients Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (Study P04823AM3)(TERMINATED)
Condition(s): Hepatitis C, Chronic; Insulin Resistance Last Updated: February 8, 2011Terminated
11
Study of DEB025/Alisporivir Plus Pegylated Interferon alfa2a and Ribavirin and Boceprevir Plus Pegylated Interferon alfa2a and Ribavirin in African American Chronic Hepatitis C Genotype 1 Patients That Have Never Received Treatment for Their Hepatitis C
Condition(s): Hepatitis C; Liver Disease Last Updated: April 20, 2012Active, not recruiting
12
Prasugrel Versus Placebo in Adult Sickle Cell Disease
Condition(s): Sickle Cell Anemia Last Updated: April 9, 2012Completed
13
Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients
Condition(s): Chronic Hepatitis C Last Updated: January 28, 2009Recruiting
14
PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)
Condition(s): Hepatitis C, Chronic Last Updated: July 25, 2008Completed
15
Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children
Condition(s): Hypochondroplasia Last Updated: September 7, 2012Active, not recruiting
16
A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Condition(s): Hepatitis C Last Updated: May 15, 2013Recruiting
17
A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit
Condition(s): Infection; Pneumonia Last Updated: January 7, 2010Completed
18
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
Condition(s): Secondary Progressive Multiple Sclerosis Last Updated: February 12, 2013Recruiting
19
Cross Linking for Treatment of Corneal Infection
Condition(s): Infectious Keratitis Last Updated: May 8, 2013Recruiting
20
A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
Condition(s): Moderate and Severe Plaque Psoriasis Last Updated: August 31, 2012Completed
